Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Siemens invests $300m in Walpole, Mass facility
Siemens Healthineers said today it is investing approximately $300 million over 4 years into its Walpole, Mass.-based laboratory diagnostics manufacturing and R&D facility.
The Walpole facility currently employs 700 employees and is the main manufacturing center for the company’s Advia Centaur assays and for molecular and blood gas testing consumables, Siemens said. Read more
4. Zimmer Biomet closes $1B senior debt offering
Zimmer Biomet said today it closed its an offering of Euro-dominated senior notes, bringing in over $1 billion.
The company brought in $530 million (EU €500 million) in principal amount of 1.414% senior unsecured notes due 2022 and an additional $530 million (EU €500 million) principal amount of 2.425% senior unsecured notes due 2026. Read more
3. Intuitive Surgical boosts share repurchasing program to $3B
Intuitive Surgical said today its board of directors has increased the authorized amount available under its share repurchase program to $3 billion.
The Pleasanton, Calif.-based company said the timing and total amount of stock repurchases will depend on market conditions, and may be made in open market purchases, private transactions, accelerated share repurchase programs, issuer self-tender offers and otherwise. Read more
2. Obama signs 21st Century Cures Act
President Obama yesterday signed the 21st Century Cures Act into law, the last step for the bill which has been 2 years in the making.
Last week, the U.S. Senate voted 94-5 to pass the 21st Century Cures Act, which sent the measure to President Barack Obama. Read more
1. J&J’s Codman Neuro picks up Pulsar Vascular
Johnson & Johnson‘s Codman Neuro said last week it picked up Pulsar Vascular, which produces the PulseRider device for treating brain aneurysms, for an undisclosed amount.
The PulseRider is designed to shore up the blood vessels around wide-necked aneurysms at or near a bifurcation of the basilar tip or carotid terminus and facilitate the implantation of an embolization coil, without obstructing blood flow through the vessels, according to the company’s website. Read more
